Renal metabolic profiling of early renal injury and renoprotective effects of Poria cocos epidermis using UPLC Q-TOF/HSMS/MSE

Journal of Pharmaceutical and Biomedical Analysis

Volumn 81-82, Issue , 2013, Pages 202-209

  Zhao, Ying Yong ^a   Lei, Ping ^b   Chen, Dan Qian ^a   Feng, Ya Long ^a   Bai, Xu ^c  

^a NORTHWEST UNIVERSITY   (China)

^b Shaanxi Microbiology Institute   (China)

^c Waters Technologies Shanghai Ltd   (China)

Author keywords

Chronic kidney disease; Metabonomics; MSE; Poria cocos epidermis; Ultra performance liquid chromatography

Indexed keywords

4 CRESOLSULFATE; ALLANTOIN; BIOLOGICAL MARKER; DOCOSAHEXAENOIC ACID; FATTY ACID; HIPPURIC ACID; ICOSAPENTAENOIC ACID; INDICAN; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHATIDYLETHANOLAMINE; PHENOL DERIVATIVE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; PORIA COCOS EPIDERMIS; PORIA COCOS EXTRACT; PURINE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DRUG EFFICACY; FATTY ACID METABOLISM; KIDNEY INJURY; KIDNEY METABOLISM; MALE; METABOLITE; METABOLOMICS; NONHUMAN; PARTIAL LEAST SQUARES REGRESSION; PHOSPHOLIPID METABOLISM; PORIA COCOS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PURINE METABOLISM; RAT; RENAL PROTECTION; SIGNAL TRANSDUCTION; TIME OF FLIGHT MASS SPECTROMETRY; TRYPTOPHAN METABOLISM; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY COUPLED WITH QUADRUPOLE TIME OF FLIGHT HIGH SENSITIVITY MASS SPECTROMETRY;

ANIMALS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DRUGS, CHINESE HERBAL; LEAST-SQUARES ANALYSIS; MALE; MASS SPECTROMETRY; MEDICINE, CHINESE TRADITIONAL; METABOLOMICS; PORIA; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY, CHRONIC;

EID: 84877836297     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2013.03.028     Document Type: Article

References (60)

1. St Peter W.L., Khan S.S., Ebben J.P., Pereira B.J., Collins A.J. Chronic kidney disease: the distribution of health care dollars. Kidney Int. 2004, 66:313-321.
2. Perrone R.D., Madias N.E., Levey A.S. Serum creatinine as an index of renal function: new insights into old concepts. Clin. Chem. 1992, 38:1933-1953.
3. Nicholson J.K., Lindon J.C., Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29:1181-1189.
4. Lindon J.C., Nicholson J.K. Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annu. Rev. Anal. Chem. (Palo Alto Calif) 2008, 1:45-69.
5. Fliser D., Novak J., Thongboonkerd V., Argiles A., Jankowski V., Girolami M., Jankowski J., Mischak H. Advances in urinary proteome analysis and biomarker discovery. J. Am. Soc. Nephrol. 2007, 18:1057-1071.
6. Wishart D.S., Tzur D., Knox C., Eisner R., Guo A.C., Young N., Cheng D., Jewell K., Arndt D., Sawhney S., Fung C., Nikolai L., Lewis M., Coutouly M., Forsythe I., Tang P., Shrivastava S., Jeroncic K., Stothard P., Amegbey G., Block D., Hau D.D., Wagner J., Miniaci J., Clements M., Gebremedhin M., Guo N., Zhang Y., Duggan G.E., Macinnis G.D., Weljie A.M., Dowlatabadi R., Bamforth F., Clive D., Greiner R., Li L., Marrie T., Sykes B.D., Vogel H.J., Querengesser L. HMDB: the human metabolome database. Nucleic Acids Res. 2007, 35:D521-D526.
7. Anonymous The Inner Canon of Emperor Huang, Chinese Medical Ancient Books Publishing House, Beijing, 2003.
8. Lee K.Y., Jeon Y.J. Polysaccharide isolated from Poria cocos sclerotium induces NF-jB/Rel activation and iNOS expression in murine macrophages. Int. Immunopharmacol. 2003, 3:1353-1362.
9. China Medical Science Press, Beijing, 2010, p. 224-225.
10. Ríos J.L. Chemical constituents and pharmacological properties of Poria cocos. Planta Med. 2011, 77:681-691.
11. Akihisa T., Nakamura Y., Tokuda H., Uchiyama E., Suzuki T., Kimura Y., Uchikura K., Nishino H. Triterpene acids from Poria cocos and their anti-tumor-promoting effects. J. Nat. Prod. 2007, 70:948-953.
12. Zheng Y., Yang X.W. Two new lanostane triterpenoids from Poria cocos. J. Asian Nat. Prod. Res. 2008, 10:289-292.
13. Zheng Y., Yang X.W. Poriacosones A and B: two new lanostane triterpenoids from Poria cocos. J. Asian Nat. Prod. Res. 2008, 10:640-646.
14. Sekiya N., Goto H., Shimada Y., Endo Y., Sakakibara I., Terasawa K. Inhibitory effects of triterpenes isolated from hoelen on free radical-induced lysis of red blood cells. Phytother. Res. 2003, 17:160-162.
15. Wang Y., Zhang M., Ruan D., Shashkov A.S., Kilcoyne M., Savage A.V., Zhang L. Chemical components and molecular mass of six polysaccharides isolated from the sclerotium of Poria cocos. Carbohyd. Res. 2004, 339:327-334.
16. Chen Y.Y., Chang H.M. Antiproliferative and differentiating effects of polysaccharide fraction from fu-ling (Poria cocos) on human leukemic U937 and HL-60 cells. Food Chem. Toxicol. 2004, 42:759-769.
17. Tai T., Akahori A., Shingu T. Triterpenes of Poria cocos. Phytochemistry 1993, 32:1239-1244.
18. Tai T., Shingu T., Kikuchi T., Tezuka Y., Akahor A. Triterpenes from the surface layer of Poria cocos. Phytochemistry 1995, 39:1165-1169.
19. Yang C.H., Zhang S.F., Liu W.Y., Zhang Z.J., Liu J.H. Two new triterpenes from the surface layer of Poria cocos. Helv. Chim. Acta 2009, 92:660-667.
20. Zhao Y.Y., Feng Y.L., Du X., Xi Z.H., Cheng X.L., Wei F. Diuretic activity the ethanol and aqueous extracts of the surface layer of Poria cocos in rat. J. Ethnopharmacol. 2012, 144:775-778.
21. Deng G.M., Xu J. Poriatin: a potential aldosterone antagonist. Chin. J. Antibiot. 1992, 17:34-37.
22. Guney I., Selcuk N.Y., Altintepe L., Atalay H., Başarali M.K., Büyükbaş S. Antifibrotic effects of aldosterone receptor blocker (spironolactone) in patients with chronic kidney disease. Ren. Fail. 2009, 31:779-784.
23. Fujisawa G., Okada K., Muto S., Fujita N., Itabashi N., Kusano E., Ishibashi S. Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats. Kidney Int. 2004, 66:1493-1502.
24. Zhao Y.Y., Xie R.M., Chao X., Zhang Y.M., Lin R.C., Sun W.J. Bioactivity-directed isolation, identification of diuretic compounds from Polyporus umbellatus. J. Ethnopharmacol. 2009, 126:184-187.
25. Zhao Y.Y., Zhang L., Mao J.R., Cheng X.H., Lin R.C., Zhang Y., Sun W.J. Ergosta-4,6,8(14),22-tetraen-3-one isolated from Polyporus umbellatus prevents early renal injury in aristolochic acid-induced nephropathy rats. J. Pharm. Pharmacol. 2011, 63:1561-1581.
26. Zhao Y.Y., Zhao Y., Zhang Y., Lin R.C., Sun W.J. Qualitative and quantitative analysis of the diuretic component ergone in Polyporus umbellatus by HPLC with fluorescence detection and HPLC-APCI-MS/MS. Pharmazie 2009, 64:366-370.
27. Zhao Y.Y., Cheng X.L., Wei F., Bai X., Lin R.C. Effect of ergosta-4,6,8(14),22-tetraen-3-one (ergone) on adenine-induced chronic renal failure rat: a serum metabonomics study based on ultra performance liquid chromatography/high-sensitivity mass spectrometry coupled with MassLynx i-FIT algorithm. Clin. Chim. Acta 2012, 413:1438-1445.
28. E data collection technique. Process Biochem. 2012, 47:1980-1987.
29. E-based metabonomics for adenine-induced changes in metabolic profiles of rat faeces and intervention effects of ergosta-4,6,8(14),22-tetraen-3-one. Chem.-Biol. Interact. 2013, 301:31-38.
30. Lao Y.M., Jiang J.G., Yan L. Application of metabonomic analytical techniques in the modernization and toxicology research of traditional Chinese medicine. Brit. J. Pharmacol. 2009, 157:1128-1141.
31. Roux A., Lison D., Junot C., Heilier J.F. Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: a review. Clin. Biochem. 2011, 44:119-135.
32. Zhao Y.Y., Cheng X.L., Wei F., Xiao X.Y., Sun W.J., Zhang Y.M., Lin R.C. Serum metabonomics study of adenine-induced chronic renal failure rat by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Biomarkers 2012, 17:48-55.
33. Zhao Y.Y., Liu J., Cheng, Wei F., Bai X., Lin R.C. Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS. Clin. Chim. Acta 2012, 413:642-649.
34. E. J. Proteome Res. 2013, 12:692-703.
35. E data collection technique. Biomarkers 2012, 17:721-729.
36. Zhao Y.Y., Feng Y.L., Bai X., Tan X.J., Lin R.C., Mei Q. Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism. Plos One 2013, 8:e59617.
37. Kaori K., Yoshiharu I., Ryoko T., Atsuko E., Kenjiro M., Toshimitsu N. Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry. J. Chromatogr. B 2010, 878:2997-3002.
38. Rhee E.P., Souza A., Farrell L., Pollak M.R., Lewis G.D., Steele D.J., Thadhani R., Clish C.B., Greka A., Gerszten R.E. Metabolite profiling identifies markers of uremia. J. Am. Soc. Nephrol. 2010, 21:1041-1051.
39. Dyerberg J. Linoleate-derived polyunsaturated fatty acids and prevention of atherosclerosis. Nutr. Rev. 1986, 44:125-134.
40. James M.J., Gibson R.A., Cleland L.G. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr. 2000, 71:S343-S348.
41. Calder P.C. Polyunsaturated fatty acids, inflammation, and immunity. Lipids 2001, 36:1007-1024.
42. Calder P.C. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 2003, 38:343-352.
43. Lee T.H., Austen K.F. Arachidonic acid metabolism by the 5-lipoxygenase pathway, and the effects of alternative dietary fatty acids. Adv. Immunol. 1986, 39:145-175.
44. Vanholder R., De Smet R. Pathophysiologic effects of uremic retention solutes. J. Am. Soc. Nephrol. 1999, 10:1815-1823.
45. Niwa T., Nomura T., Sugiyama S., Miyazaki T., Tsukushi S., Tsutsui S. The protein metabolite hypothesis, a model for the progression of renal failure: an oral sorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Kidney Int. 1997, 52:S23-S28.
46. Dou L., Bertrand E., Cerini C., Faure V., Sampol J., Vanholder R., Berland Y., Brunet P. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int. 2004, 65:442-451.
47. Schepers E., Meert N., Glorieux G., Goeman J., Van der Eycken J., Vanholder R. P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol. Dial. Transpl. 2007, 22:592-596.
48. Bammens B., Evenepoel P., Keuleers H., Verbeke K., Vanrenterghem Y. Free serum concentrations of the proteinbound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int. 2006, 69:1081-1087.
49. Meijers B.K., Bammens B., De Moor B., Verbeke K., Vanrenterghem Y., Evenepoel P. Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int. 2008, 73:1174-1180.
50. Lin C.J., Wu C.J., Pan C.F., Chen Y.C., Sun F.J., Chen H.H. Serum protein-bound uremic toxins and clinical outcomes in hemodialysis patients. Nephrol. Dial. Transpl. 2010, 25:3693-3700.
51. Deguchi T., Takemoto M., Uehara N., Lindup W.E., Suenaga A., Otagiri M. Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats. J. Pharmacol. Exp. Ther. 2005, 314:932-938.
52. Engle S.J., Stockelman M.G., Chen J., Boivin G., Yum M.N., Daviest P.M., Ying M.Y., Sahota A., Simmondst H.A., Stambrook P.J., Tischfield J.A. Adenine phosphoribosyltransferase-deficient mice develop 2,8-dihydroxyadenine nephrolithiasis. Proc. Natl. Acad. Sci. USA 1996, 93:5307-5312.
53. Wyngaarden J.B., Dunn T.J. 8-hydroxyadenine as the metabolic intermediate in the oxidation of adenine to 2,8-dihydroxyadenine by xanthine oxidase. Arch. Biochem. Biophys. 1957, 70:150-156.
54. De Vries A., Sperling O. Implications of disorders of purine metabolism for the kidney and the urinary tract. Ciba Found. Symp. 1977, 48:179-206.
55. Yokozawa T., Zheng P.D., Oura H., Koizumi F. Animal model of adenine-induced chronic renal failure in rats. Nephron 1986, 44:230-234.
56. Pawlak K., Mysliwiec M., Pawlak D. Oxidative stress, phosphate and creatinine levels are independently associated with vascular endothelial growth factor levels in patients with chronic renal failure. Cytokine 2008, 43:98-101.
57. Rahman A., Ahmed S., Vasenwala S.M., Athar M. Glyceryl trinitrate, a nitric oxide donor, abrogates ferric nitrilotriacetate-induced oxidative stress and renal damage. Arch. Biochem. Biophys. 2003, 418:71-79.
58. Maldonado P., Barrera D., Rivero I., Mata R., Medina C.O., Hernandez P.R., Pedraza C.J. Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage. Free Radic. Biol. Med. 2003, 35:317-324.
59. Maldonado P., Barrera D., Medina C.O., Hernandez P.R., Ibarra R.M., Pedraza C.J. Aged garlic extract attenuates gentamicin induced renal damage and oxidative stress in rats. Life Sci. 2003, 73:2543-2556.
60. Bassa B.V., Noh J.W., Ganji S.H., Shin M.K., Roh D.D., Kamanna V.S. Lysophosphatidylcholine stimulates EGF receptor activation and mesangial cell proliferation: regulatory role of Src and PKC. Biochim. Biophys. Acta 2007, 1771:1364-1371.